Tamoxifen resistant and refractory breast cancer: the value of aromatase inhibitors

Drugs
Paul E Goss, Kathrin Strasser

Abstract

Tamoxifen has dominated endocrine treatment of breast cancer for over two decades. It is useful in metastatic breast cancer, adjuvant therapy, preoperative treatment, ductal carcinoma-in-situ and chemoprevention. However, breast cancer may be refractory to tamoxifen or develop resistance to it with ongoing treatment. This resistance involves several mechanisms including receptor mutation causing 'estrogen hypersensitivity' and an increasing agonist effect of tamoxifen. Megestrol (megestrol acetate), in North America, and aminoglutethimide, in Europe, have been the traditional second line therapies after tamoxifen in advanced breast cancer. Aromatase (estrogen synthetase) inhibitors are a logical alternative to tamoxifen to antagonise the effects of estrogen on breast cancer. The third-generation non-steroidal aromatase inhibitors anastrozole, letrozole and vorozole, and the steroidal inhibitor exemestane, have been studied after tamoxifen versus either megestrol or aminoglutethimide. They showed enhanced efficacy and significantly superior toxicity profiles. Compliance with the inhibitors was also significantly better than with the traditional treatments. Aromatase inhibitors have most recently been shown to be superior to tamo...Continue Reading

References

Jan 1, 1976·British Journal of Cancer·W R Miller, A P Forrest
Mar 1, 1992·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P BoluferR Romero
Nov 1, 1991·Molecular Endocrinology·W L McGuireS A Fuqua
Dec 20, 1990·The Journal of Steroid Biochemistry and Molecular Biology·W R MillerW J Jack
Oct 1, 1987·Steroids·W R Miller, J O'Neill
Dec 1, 1983·The Journal of Clinical Endocrinology and Metabolism·N Tilson-MallettR J Santen
Sep 1, 1980·The Journal of Clinical Endocrinology and Metabolism·R J SantenS A Wells
Jan 1, 1994·Breast Cancer Research and Treatment·R W Brueggemeier
Jan 1, 1994·Breast Cancer Research and Treatment·H V Vanden BosscheL M Koymans
Nov 1, 1994·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P E Goss, K M Gwyn
Mar 1, 1996·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·W JonatM Azab
Aug 1, 1996·The Journal of Steroid Biochemistry and Molecular Biology·M M BilimoriaV C Jordan
Jul 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·M DowsettS R Johnston
Apr 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·N Harada
Apr 1, 1997·The Journal of Steroid Biochemistry and Molecular Biology·W R MillerJ Telford
Jun 1, 1997·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·B ThürlimannA Goldhirsch
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P DombernowskyP F Trunet
Jun 10, 1998·Steroids·J SzymczakJ Daroszewski
Jul 31, 1999·Science·J D NorrisD P McDonnell
Mar 24, 2000·Endocrine-related Cancer·A BrodieB Long
Mar 24, 2000·Endocrine-related Cancer·R J SantenL Berstein

❮ Previous
Next ❯

Citations

Dec 4, 2003·European Journal of Medicinal Chemistry·Dharam Paul JindalRanju Gupta
Dec 13, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Antonio C WolffDaniel F Hayes
Jan 1, 2009·International Journal of General Medicine·Catherine AbrialF Penault-Llorca
Dec 8, 2005·Journal of Drug Targeting·Francesca GrecoRuth Duncan
Oct 19, 2007·The Journal of Steroid Biochemistry and Molecular Biology·Gauri J SabnisAngela Brodie
Mar 3, 2006·Archives of Oral Biology·Yi-Shing Lisa ChengJiahuan Ding
Feb 15, 2005·Cancer Treatment Reviews·O C FreedmanM J Clemons
Feb 16, 2015·Critical Reviews in Oncology/hematology·Jean-Philippe SpanoAnthony Gonçalves
Oct 15, 2013·Molecular and Cellular Endocrinology·N Patani, L-A Martin
Jul 24, 2013·Evidence-based Child Health : a Cochrane Review Journal·Damon ShorterDavid A Osborn
Jul 22, 2004·The Oncologist·William J Gradishar
Jan 25, 2003·Current Opinion in Obstetrics & Gynecology·John R Benson, Vassilis Pitsinis

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy and Asthma

Allergy and asthma are inflammatory disorders that are triggered by the activation of an allergen-specific regulatory t cell. These t cells become activated when allergens are recognized by allergen-presenting cells. Here is the latest research on allergy and asthma.

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.